Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Crivellari

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Investigational New Drugs|January 1, 1987
Phase II study of esorubicin (4'-deoxydoxorubicin) in locally advanced or metastatic head and neck carcinomaS Frustaci, G Gasparini, A Veronesi, et al.
Tumori|July 25, 1998
Tamoxifen as adjuvant after surgery for breast cancer and tamoxifen or placebo as chemoprevention in healthy women: different compliance with treatmentA Veronesi, M A Pizzichetta, M A Ferlante, et al.
Cancer Treatment Reports|March 1, 1987
Phase II trial of esorubicin in patients with advanced melanomaS Frustaci, G Gasparini, E Galligioni, et al.
Tumori|May 1, 1997
High-dose epirubicin in locally advanced operable noninflammatory breast cancer: a feasibility trialD Crivellari, A Buonadonna, C Sacco, et al.
Tumori|April 25, 2000
Continuous infusion fluorouracil in the management of advanced breast cancer: a phase II studyD Crivellari, M D Magri, A Buonadonna, et al.
Tumori|April 30, 1989
Retrospective analysis of the CYVADIC regimen in advanced soft tissue sarcomasS Frustaci, G Lo Re, D Crivellari, et al.
Cancer Chemotherapy and Pharmacology|February 3, 2009
Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancerFranco Nolè, D Crivellari, R Mattioli, et al.
Journal of Chemotherapy (Florence, Italy)|June 2, 2006
Oral etoposide in elderly patients with advanced non small cell lung cancer: a clinical and pharmacological studyR Sorio, G Toffoli, D Crivellari, et al.
Clinical Chemistry|May 1, 1990
High predictivity of galactosyl-hydroxylysine in urine as an indicator of bone metastases from breast cancerL Moro, C Gazzarrini, C Modricky, et al.
Cancer Investigation|January 1, 1989
Low-dose aminoglutethimide plus steroid replacement in advanced breast cancer patients resistant to conventional therapiesD Crivellari, E Galligioni, S Frustaci, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Investigational New Drugs|January 1, 1987
Phase II study of esorubicin (4'-deoxydoxorubicin) in locally advanced or metastatic head and neck carcinomaS Frustaci, G Gasparini, A Veronesi, et al.
Tumori|July 25, 1998
Tamoxifen as adjuvant after surgery for breast cancer and tamoxifen or placebo as chemoprevention in healthy women: different compliance with treatmentA Veronesi, M A Pizzichetta, M A Ferlante, et al.
Cancer Treatment Reports|March 1, 1987
Phase II trial of esorubicin in patients with advanced melanomaS Frustaci, G Gasparini, E Galligioni, et al.
Tumori|May 1, 1997
High-dose epirubicin in locally advanced operable noninflammatory breast cancer: a feasibility trialD Crivellari, A Buonadonna, C Sacco, et al.
Tumori|April 25, 2000
Continuous infusion fluorouracil in the management of advanced breast cancer: a phase II studyD Crivellari, M D Magri, A Buonadonna, et al.
Tumori|April 30, 1989
Retrospective analysis of the CYVADIC regimen in advanced soft tissue sarcomasS Frustaci, G Lo Re, D Crivellari, et al.
Cancer Chemotherapy and Pharmacology|February 3, 2009
Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancerFranco Nolè, D Crivellari, R Mattioli, et al.
Journal of Chemotherapy (Florence, Italy)|June 2, 2006
Oral etoposide in elderly patients with advanced non small cell lung cancer: a clinical and pharmacological studyR Sorio, G Toffoli, D Crivellari, et al.
Clinical Chemistry|May 1, 1990
High predictivity of galactosyl-hydroxylysine in urine as an indicator of bone metastases from breast cancerL Moro, C Gazzarrini, C Modricky, et al.
Cancer Investigation|January 1, 1989
Low-dose aminoglutethimide plus steroid replacement in advanced breast cancer patients resistant to conventional therapiesD Crivellari, E Galligioni, S Frustaci, et al.
Pageof 9